Press Release

5.8% growth for Veterinary Therapeutics Market by 2025, global revenue to reach $ 54,968.3 Mn

Veterinary Therapeutics Market to Exhibit 5.8% CAGR Driven by Rising Demand for Meat Products, says Fortune Business Insights

In 2017, the global market for veterinary therapeutics was valued at US$ 35,005.2 Mn and is projected to reach a value of US$ 54,968.3 Mn by 2025. Furthermore, the report predicts the global market to expand at a CAGR of 5.8% during the forecast period.

Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-therapeutics-market-100138

Some of the Main Key Players Covered in the Report:

Veterinary Therapeutics Market
Veterinary Therapeutics Market
  • Merck Animal Health
  • Zoetis Inc.
  • Elanco
  • Merial
  • Bayer Pharmaceuticals
  • Bayer
  • Boehringer Ingelheim
  • CEVA LogisticsVetoquinol S.A.
  • IDEXX
  • Virbac

The Veterinary Therapeutics Market is projected to grow at a significant rate on account of rising demand for meat and meat products. Fortune Business Insights in its new report, titled “Veterinary Therapeutics Market Size, Share and Global Trend by Product Type (Drugs, Vaccines), Animal Type (Companion, Livestock), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) and Geography Forecast till 2025” finds that the growing population across the world is positively impacting the veterinary therapeutics market.

In addition to this, fast approval on new products is also driving the therapeutic drugs segment. However, increasing number of restrictions on the use of antibiotics may offset the segment’s growth. Vaccines are also projected to gain popularity among other veterinary therapeutic products in the upcoming years. The rising need for treating diseases in animals is the major factor driving this segment. Among regions, North America is expected to lead the global veterinary therapeutics market.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-therapeutics-market-100138

Segmentation:

By Animal Type

  • Companion
  • Livestock

By Product Type

  • Medicated Feed Additives
  • Drugs
  • Vaccine

By Distribution Channels

 

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores

By Route of Administration

  • Oral
  • Parenteral
  • Topical

Focus on Expanding Product Portfolio May Offer Promising Growth Opportunities

Some of the leading players operational in the global market for veterinary therapeutics are Zoetis, Intervet Inc., Vetoquinol S.A., Elanco, Merial, IDEXX Laboratories, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Virbac, and Ceva. In 2017, Zoetis was the leading player in the global market with the presence of strong product portfolio. One of the chief strategies adopted by companies is strengthening their product portfolio by introducing new products. This is projected to generate huge growth opportunities for the global veterinary therapeutics market during the forecast period between 2017 and 2025.

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close